The Division specializes in a wide range of malignant diseases and blood disorders and serves as a statewide referral center for solid tumor oncology, malignant and benign hematology, and bone marrow transplant. The Division's faculty is heavily engaged in numerous multidisciplinary tumor boards and clinics at the, ensuring that clinicians are able to collaborate across disciplines on patient care and allowing many patients with malignancies to see all of their physicians in one appointment.
The Hollings Cancer Center is the largest academic cancer center in South Carolina. It is the state's only National Cancer Institute (NCI) designated cancer center and one of only 69 NCI centers in the United States
The Division's faculty members are equally committed to research and lead efforts in the laboratory as well as conduct clinical trials. Our comprehensive treatment protocols include an ever-expanding clinical trials portfolio offering studies for most types of cancer and blood disorders. As an NCI-Designated Cancer Center, Hollings offers clinical trials and therapies not available elsewhere in South Carolina.
The Division’s fellowship program continues to recruit top tier candidates and is the only hematology oncology training program in the state of South Carolina. The program provides each fellow extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation.